We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

7 hedge funds and large institutions have $6.1M invested in Eterna Therapeutics in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 7 → 7 (0)

0.23% less ownership

Funds ownership: 21.63% → 21.4% (-0.23%)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $9K

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Virtu KCG Holdings
Virtu KCG Holdings
New York
-$8K
2
Citigroup
Citigroup
New York
-$1K

ERNA Hedge Fund Activity: Q3 2014 in Review

7 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q3 2014, worth a combined $6.1M — down 38% from $9.9M a quarter earlier.

Fund positioning in ERNA was balanced in Q3 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Virtu KCG Holdings, cutting an estimated $8K.

  • 7 institutional investors held Eterna Therapeutics (ERNA) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $6.1M of Eterna Therapeutics stock for Q3 2014, down 38% quarter-over-quarter.
  • 0 funds opened new Eterna Therapeutics positions in Q3 2014 and 0 closed out.
  • The largest Eterna Therapeutics seller in Q3 2014 was Virtu KCG Holdings, an estimated $8K sold.

Based on aggregated 13F filings for Q3 2014.